Massive study tests whether a stronger flu shot saves more seniors from hospitalization
NCT ID NCT06506812
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study combines data from two large trials in Denmark and Spain involving over 466,000 older adults. It compares the high-dose flu vaccine (Efluelda/Fluzone High-Dose) to the standard-dose flu shot to see which better prevents severe outcomes like hospitalization for flu or pneumonia. The goal is to get clearer answers by pooling data from different countries and seasons.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High-dose quadrivalent influenza vaccine (Efluelda/Fluzone High-Dose Quadrivalent) vs. standard-dose quadrivalent influenza vaccine
What this could lead to
If high-dose vaccine proves more effective, it could become the preferred flu shot for older adults, reducing hospitalizations and deaths from flu.
What could go wrong
This is a pooled analysis of completed trials, not a new experiment. The results may not apply to all populations or flu seasons, and high-dose vaccine may cause more local reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
Hellerup, Capital Region, 2900, Denmark